Neogen Corp. (NEOG)
NASDAQ
Closed
Oct 8, 2026
Day's Range
11.1352 wk Range
5.37Overview - NEOG - Neogen Corp.
Key Statistics
Valuation
Enterprise Value
3.62B
P/E (Trailing)
‪865.00‬
P/E (Forward)
‪36.00‬
PEG Ratio
‪-8.80‬
Price / Sales (TTM)
‪3.42‬
Price / Book
‪1.42‬
EV / EBITDA
‪38.30‬
Profitability
Gross Margin
‪47.84%‬
Profit Margin
‪-0.90%‬
Operating Margin
‪1.37%‬
Return on Assets
‪-0.39%‬
Return on Equity
‪-0.37%‬
Ownership
Shares Outstanding
217.70M
Float
217.09M
Short % of Shares Outstanding
‪6.84%‬
Held by Insiders
‪0.74%‬
Held by Institutions
‪110.95%‬
Price stats
Beta
‪1.76‬
50-Day Avg
‪11.62‬
200-Day Avg
‪9.84‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
4 analysts
Average price target
‪$ 13.33‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - NEOG - Neogen Corp.
Peers - NEOG - Neogen Corp.
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
Profile Summary - NEOG - Neogen Corp.
About
Neogen Corporation develops, manufactures, and markets products and services dedicated to food and animal safety worldwide. Operating through two primary segments, Food Safety and Animal Safety, the company provides diagnostic test kits, dehydrated culture media, and complementary solutions to detect foodborne…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
